On June 1st and 2nd Exco InTouch held a Free Webinar entitled: Using mobile-PRO for Patient Data Capture with Validated Scales and Assessments – How the m-WOMAC NRS3.1 index was successfully validated and deployed in an Osteoarthritis study

During this FREE WEB Seminar the attendees heard first hand:

Exco InTouch, the leading provider of patient communication solutions for the pharmaceutical and healthcare sectors, has carried out a poll demonstrating the effectiveness of cellphone technology in clinical studies, following its recent webinar on “Moving from ePRO to mobile-PRO”. The webinar, in collaboration with Novartis, discussed distinct advantages of ePRO (electronic reported outcomes) using cellphone technology, known in the industry as mobile-PRO (mobile patient reported outcomes), to accurately and reliably capture real-time patient data.

As with all services, we at Exco InTouch are asked supporting questions around the claims that are made in the sales and marketing literature. Therefore we would like to take this opportunity to share with you the top four findings from some analysis we have undertaken on the use of our market leading ePRO CELL service in clinical studies. This analysis looked within the study population and compared the compliance rates between those who had access to ePRO CELL and those who used traditional reminder methods.

When considering the communications platform to be used within your clinical trials, it is interesting to note that geographically there are subtle differences in how the end user is able to interface with your study.  Infrastructure differences between the developed and developing world are often overlooked in study design and delegates at the recent CITA wireless 2010 conference were told that the mobile phone is becoming a great equalizer between the haves and have-nots around the world.

Two recent reports have highlighted the benefits of using cell phone technology within Clinical Trials to improve patient compliance. 

The first, a collaborative paper between MDS Pharma services and Exco InTouch, reported that the use of outreach via cell phone, resulted in typical response rates of 50% to 60% compared to approximately 5% when using traditional paper-based methods.  The authors concluded that the